Once finalized by Verra, the Methodology will pave the way for dynaCERT’s patented HydraGEN™ Technology and HydraLytica™ Telematics to be deployed for the certification of Carbon Credits on a global basis. Emission reductions through improved efficiency of vehicle fleets and approved VCS Methodology Revision VMR0004 that included mobile machinery.” The Methodology is based on the CDM methodology AMS-III.BC. fleets of trucks, buses, cars, taxis or motorized tricycles, excavators, cranes), resulting in reduced fuel usage and GHG emissions. Verra indicates the following: “This Methodology applies to project activities that improve efficiency of vehicle fleets and mobile machinery (e.g. The Methodology for Improved Efficiency of Fleet Vehicles and Combustion Engines can be viewed and downloaded here:
![vcs diamond to low vcs diamond to low](https://img.joomcdn.net/e04b9819032ffee9de450dbc3ed79bd3230693af_original.jpeg)
(TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (” dynaCERT ” or the “Company”) is pleased to announce that the executive management of Verra, which manages the world’s largest greenhouse gas program, the Verified Carbon Standard, has announced to dynaCERT that it’s Methodology in respect of its Carbon Credit Certification has reached a new important stage.Īs part of its normal required process of certification, Verra has advanced dynaCERT ’s Carbon Credit Methodology to its Global Public Comment Stage in order to meet Verra’s Verified Carbon Standard. With proven superiority over traditional helical threadforms, Diamond Orthopedic is the new fixation standard in orthopedics.DynaCERT Inc. Diamond Orthopedic is the exclusive provider of faceted threadform technology for orthopedic applications worldwide.
VCS DIAMOND TO LOW FULL
"We are very excited about the possibilities for this technology in a multitude of applications, from specific procedures where superior fixation is paramount, such as triple arthrodesis, to the full spectrum of applications ranging from healthy-boned athletes to compromised bone, such as osteoporotic and osteopenic bone." He adds "our faceted technology has the potential to change numerous paradigms within orthopedics, including uni-cortical fixation possibilities." About Diamond Orthopedic Diamond Orthopedic, LLC, headquartered in Charlotte, NC, is a medical device company that offers a revolutionary fixation technology to achieve better patient outcomes at a lower total cost. "Faceted bone screws offer superior fixation performance in both healthy and compromised bone," says CEO Roy Bivens. Many promising applications of the faceted threadform exist within the orthopedic market, especially in cases where compromised bone is a factor. When paired with the viscoelastic properties of bone, the faceted threadform demonstrates superior fixation as compared to conventional helical threadforms. Lower compressive stress and the reduced insertion torque required to drive the screw and/or threaded pins into bone reduces the potential for microfractures. "With the market encouragement we've received thus far, we look forward to providing surgeons and patients with this superior technology." Diamond's patented faceted threadform is designed to reduce friction and compressive stress at the bone-screw interface. "We are excited about the ability to launch our faceted bone screw technology with this round of capital investment," says Board Chairman Charlie Federico. Diamond Orthopedic has exclusive rights to market and sell over 2,500 FDA cleared SKUs of cortical, cancellous, headless compression, and external fixation screws. With its initial capital raise complete, experienced management team, seasoned advisory board, and patented new technology, Diamond Orthopedic is positioned for success in the nearly $50 billion orthopedic market. As evidenced by significant bench testing, the new threadform design demonstrates superior performance as compared to conventional helical threadforms. Diamond's signature technology is a faceted threadform that has been deployed in an FDA cleared faceted bone screw.
![vcs diamond to low vcs diamond to low](https://www.bfgcdn.com/1500_1500_90/301-0670/unparallel-newtro-vcs-climbing-shoes-detail-3.jpg)
The capital raise, led by MagnaSci Fund L.P., is the Company's first equity offering since its inception on March 1, 2017. Diamond Orthopedic, LLC, a medical device company that offers a revolutionary fixation technology to achieve better patient outcomes at a lower total cost, announced today it has successfully closed its $3.5 million seed round of equity funding.